SecBot SecBot
6-K ·Filed May 21, 2026

MCUJF

MEDICURE INC
NEUTRAL
Impact 3/10
Horizonimmediate Processed5mo ago SEC0001654954-26-005246
Notable filing: 6-K
Actionable Insight • Neutral

Routine governance filing with no price-sensitive information. Monitor upcoming quarterly filings for any changes in revenue trends at the pharmacy or pharmaceutical segments.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
MCUJF ▲ +15.00% at T+60d
NEUTRAL call +15.00% · α vs SPY +11.81% · entry $0.8000 → $0.9200
Entry = T+0 close
May 21, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.59%
$0.8000
settled 5mo ago
T+5d
+3.75%
call +3.75% · α +2.09%
$0.8300
settled 5mo ago
T+20d
-16.25%
call -16.25% · α -14.83%
$0.6700
settled 4mo ago
T+60d
+15.00%
call +15.00% · α +11.81%
$0.9200
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Medicure Inc. filed a 6-K reporting the results of its Annual General Meeting, where all resolutions passed, including the election of five directors and reappointment of Ernst & Young as auditor. The company appointed Kerrie Hayes as a new independent director and announced the departure of long-serving director Peter Quick. This is a routine governance filing with no material financial or operational updates.

Key Facts

  • 5,237,796 common shares (50.19% of outstanding) were voted at the AGM.
  • All resolutions passed: board set at five directors, five nominees elected, Ernst & Young LLP reappointed as auditors.
  • Kerrie Hayes appointed as independent director; Peter Quick stepped down after 20 years.
  • No financial results, guidance, or material operational updates were disclosed.

Financial Impact

No financial data disclosed in this filing.

Risk Factors

  • Low liquidity on OTC markets may amplify price moves on any news flow.
  • No business or financial updates provided in this filing — not a catalyst.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-005246
Document: med_6k.htm0001654954-26-005246
Document: 0001654954-26-005246-index-headers.html0001654954-26-005246
Document: 0001654954-26-005246-index.html0001654954-26-005246
Document: 0001654954-26-005246.txt0001654954-26-005246
4 reports for MCUJF
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for MCUJF — sortable, filterable
TypeNow
May 21, 2026
22w ago
6-K
MIXED ★ 5/10
$0.8000 $0.9200▲ +15.00%▲ +11.81%$3.16 (+295.00%)
May 21, 2026
22w ago
6-K
NEUTRAL ★ 3/10
$0.8000 $0.9200▲ +15.00%▲ +11.81%$3.16 (+295.00%)
Apr 24, 2026
26w ago
6-K
BEARISH ★ 6/10
$0.7500 $0.8600▼ −14.67%▼ −9.59%$3.16 (−321.33%)
Apr 22, 2026
26w ago
6-K
NEUTRAL ★ 3/10
$0.9600 $0.8600▼ −10.42%▼ −15.43%$3.16 (+229.17%)
Showing 4 of 4

US Market Status

Market Closed — Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 21, 2026